These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34764423)

  • 1. Metabolomic credentialing of murine carcinogen-induced urothelial cancer.
    Afify H; Ghoneum A; Almousa S; Abdulfattah AY; Warren B; Langsten K; Gonzalez D; Casals R; Bharadwaj M; Kridel S; Said N
    Sci Rep; 2021 Nov; 11(1):22085. PubMed ID: 34764423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
    Dai YC; Wang SC; Haque MM; Lin WH; Lin LC; Chen CH; Liu YW
    PLoS One; 2017; 12(10):e0186214. PubMed ID: 29016672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine as the basis for urothelial carcinogenesis.
    He Z; Kosinska W; Zhao ZL; Wu XR; Guttenplan JB
    Mutat Res; 2012 Feb; 742(1-2):92-5. PubMed ID: 22155125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary on "tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl) nitrosamine as the basis for urothelial cell carcinogenesis." He Z, Kosinska W, Zhao ZL, Wu XR, Guttenplan JB, Department of Basic Science, New York University Dental College, NY, USA.: Mutat Res 2012;742(1-2):92-5 [Epub 2011 Dec 4].
    Scherr DS
    Urol Oncol; 2014 Feb; 32(2):214. PubMed ID: 24445298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review: BBN as an urothelial carcinogen.
    Vasconcelos-Nóbrega C; Colaço A; Lopes C; Oliveira PA
    In Vivo; 2012; 26(4):727-39. PubMed ID: 22773588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of p27 kip1 knockout mice to urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine may not simply be due to enhanced proliferation.
    Hikosaka A; Ogawa K; Sugiura S; Asamoto M; Takeshita F; Sato SY; Nakanishi M; Kohri K; Shirai T
    Int J Cancer; 2008 Mar; 122(6):1222-8. PubMed ID: 18027869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice.
    Tyagi A; Raina K; Singh RP; Gu M; Agarwal C; Harrison G; Glode LM; Agarwal R
    Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3248-55. PubMed ID: 18089718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of uroplakin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats and mice.
    Ogawa K; St John M; Luiza de Oliveira M; Arnold L; Shirai T; Sun TT; Cohen SM
    Toxicol Pathol; 1999; 27(6):645-51. PubMed ID: 10588545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor.
    Hsu JW; Hsu I; Xu D; Miyamoto H; Liang L; Wu XR; Shyr CR; Chang C
    Am J Pathol; 2013 May; 182(5):1811-20. PubMed ID: 23499463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of glutathione S-transferase M1 protein in N-butyl-N-(4-hydroxybutyl)nitrosamine-induced mouse bladder carcinogenesis.
    Chuang JJ; Dai YC; Lin YL; Chen YY; Lin WH; Chan HL; Liu YW
    Toxicol Appl Pharmacol; 2014 Sep; 279(3):322-330. PubMed ID: 24998975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
    Ozaki K; Sukata T; Yamamoto S; Uwagawa S; Seki T; Kawasaki H; Yoshitake A; Wanibuchi H; Koide A; Mori Y; Fukushima S
    Cancer Res; 1998 Sep; 58(17):3806-11. PubMed ID: 9731488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
    Grubbs CJ; Lubet RA; Koki AT; Leahy KM; Masferrer JL; Steele VE; Kelloff GJ; Hill DL; Seibert K
    Cancer Res; 2000 Oct; 60(20):5599-602. PubMed ID: 11059745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The lithium carbonate promotion of urothelial tumors in rats induced with N-butyl-N-(4-hydroxybutyl)-nitrosamine].
    Frolov AG; Pliss GB
    Vopr Onkol; 1992; 38(11):1309-13. PubMed ID: 1343160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA cytophotometric and histological analysis of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced precancerous lesions of the bladder urothelium.
    Dahm HH; von der Haar C; Rübben H
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1253-60. PubMed ID: 27033373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol-extracted propolis enhances BBN-initiated urinary bladder carcinogenesis via non-mutagenic mechanisms in rats.
    Xie XL; Gi M; Fujioka M; Doi K; Yamano S; Tachibana H; Fang H; Kakehashi A; Wanibuchi H
    Food Chem Toxicol; 2015 Sep; 83():193-200. PubMed ID: 26111810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotion effects of acetoaceto-o-toluidide on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder carcinogenesis in rats.
    Yukimatsu N; Gi M; Okuno T; Fujioka M; Suzuki S; Kakehashi A; Yanagiba Y; Suda M; Koda S; Nakatani T; Wanibuchi H
    Arch Toxicol; 2019 Dec; 93(12):3617-3631. PubMed ID: 31673724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of ERβ signaling via ERβ knockout or antagonist protects against bladder cancer development.
    Hsu I; Chuang KL; Slavin S; Da J; Lim WX; Pang ST; O'Brien JH; Yeh S
    Carcinogenesis; 2014 Mar; 35(3):651-61. PubMed ID: 24148819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations.
    Kerzeli IK; Lord M; Doroszko M; Elgendy R; Chourlia A; Stepanek I; Larsson E; van Hooren L; Nelander S; Malmstrom PU; Dragomir A; Segersten U; Mangsbo SM
    PLoS One; 2021; 16(7):e0253178. PubMed ID: 34232958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Schistosoma haematobium and N-butyl-N-(4-hydroxybutyl)nitrosamine on the development of urothelial neoplasia in the baboon.
    Hicks RM; James C; Webbe G
    Br J Cancer; 1980 Nov; 42(5):730-55. PubMed ID: 7459210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic characterization of an N-butyl-N-(4-hydroxybutyl) nitrosamine-induced mouse papillary urothelial carcinoma.
    Arantes-Rodrigues R; Pinto-Leite R; da Costa RG; Colaço A; Lopes C; Oliveira P
    Tumour Biol; 2013 Oct; 34(5):2691-6. PubMed ID: 23645214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.